Amicus Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.86 | -100% | -13.83 | -100% |
| P/S |
|
10.05 | 4.06 | 147.36% |
|
|
| P/BV |
|
25.06 | 9.39 | 166.85% |
|
|
| P/FCF |
|
-48.09 | 46.57 | -203.26% |
|
|
| Ev/Ebitda |
|
-64.19 | 17.55 | -465.75% |
|
|
| Ev/S |
|
10.55 | 4.36 | 142.14% |
|
|
| Ev/FCF |
|
-55.04 | 54.43 | -201.12% |
|
|
| E/P |
|
-0.0412 | 0.2164 | -119.04% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-16.43 | 20.15 | -181.55% | -83.51 | -80.32% |
| ROE |
|
-94.64 | -80.86 | 17.05% |
|
|
| ROA |
|
-19.49 | 6.71 | -390.24% |
|
|
| ROIC |
|
0 | 15.68 | -100% |
|
|
| ROS |
|
-37.96 | 10.56 | -459.64% |
|
|
| ROCE |
|
-45.88 | 18.05 | -354.19% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-6.04 | 2.82 | -314.41% | -4.27 | +41.44% |
| Nеt Debt/Ebitda |
|
-3.02 | 3.64 | -182.99% |
|
|
| Debt/Ratio |
|
0.5093 | 0.261 | 95.14% |
|
|
| Debt/Equity |
|
12.86 | 4.81 | 167.62% |
|
|
| Debt/Net Income |
|
-2.61 | 6.35 | -141.17% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.29 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.33 | -100% | ||
| DSI |
|
0 | 0.7376 | -100% |
|
|
| Average dividend growth |
|
0 | -3.12 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.29 | -100% |
|
|
| Average percentage for payments |
|
0 | 77.61 | -100% |
|
|
| Difference from average difference in sector |
|
-1.29 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
119.19 | 362.86 | -67.15% | ||
| Growth impulse Ebitda in 5 years |
|
-72.01 | 373.75 | -119.27% | ||
| Growth impulse Net Income in 5 years |
|
-57.47 | 454.84 | -112.64% | ||
| Growth impulse FCF in 5 years |
|
-71.7 | 306.17 | -123.42% | ||
| Growth impulse EPS in 5 years |
|
-65.3 | 455.99 | -114.32% |
IP Score
2.36/10
